New cytotoxic benzo(b)thiophenilsulfonamide 1,1-dioxide derivatives inhibit a NADH oxidase located in plasma membranes of tumour cells

被引:10
作者
Alonso, MM
Encío, I
Martínez-Merino, V
Gil, M
Migliaccio, M
机构
[1] Publ Univ Navarra, Dept Hlth Sci, Pamplona 31008, Spain
[2] Publ Univ Navarra, Dept Appl Chem, Pamplona 31006, Spain
关键词
diarylsulfonylureas; antineoplasic drugs; NADH oxidase; CCRF-CEM; plasma membrane;
D O I
10.1054/bjoc.2001.2083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A series of benzo(b)thiophenesulfonamide 1,1-dioxide derivatives (13TS) have been designed and synthesized as candidate antineoplastic drugs. Several of these compounds have shown in vitro cytotoxic activity on leukaemic CCRF-CEM cells. The cytotoxic BTS, but not the inactive ones, were able to inhibit a tumour cell-specific NADH oxidase activity present in the membrane of CCRF-CEM cells. (C) 2001 Cancer Research Campaign.
引用
收藏
页码:1400 / 1402
页数:3
相关论文
共 14 条
[1]  
Bacakova L, 1997, PHYSIOL RES, V46, P403
[2]   Synthesis and cytotoxic activity of N-(2-pyridylsulfenyl)urea derivatives.: A new class of potential antineoplastic agents. [J].
Gil, MJ ;
Mañú, MA ;
Arteaga, C ;
Migliaccio, M ;
Encío, I ;
González, A ;
Martínez-Merino, V .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (16) :2321-2324
[3]   Antitumor diarylsulfonylureas: Novel agents with unfulfilled promise [J].
Houghton, PJ ;
Houghton, JA .
INVESTIGATIONAL NEW DRUGS, 1996, 14 (03) :271-280
[4]   NOVEL AGENTS EFFECTIVE AGAINST SOLID TUMORS - THE DIARYLSULFONYLUREAS - SYNTHESIS, ACTIVITIES, AND ANALYSIS OF QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
HOWBERT, JJ ;
GROSSMAN, CS ;
CROWELL, TA ;
RIEDER, BJ ;
HARPER, RW ;
KRAMER, KE ;
TAO, EV ;
AIKINS, J ;
POORE, GA ;
RINZEL, SM ;
GRINDEY, GB ;
SHAW, WN ;
TODD, GC .
JOURNAL OF MEDICINAL CHEMISTRY, 1990, 33 (09) :2393-2407
[5]   Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro [J].
Huschtscha, LI ;
Bartier, WA ;
Ross, CEA ;
Tattersall, MHN .
BRITISH JOURNAL OF CANCER, 1996, 73 (01) :54-60
[6]   Impermeant antitumor sulfonylurea conjugates that inhibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients [J].
Kim, C ;
MacKellar, WC ;
Cho, NM ;
Byrn, SR ;
Morre, DJ .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1997, 1324 (02) :171-181
[7]  
MARTINEZMERINO V, 2000, Patent No. 0063202
[8]   Mode of action of the anticancer quassinoids -: Inhibition of the plasma membrane NADH oxidase [J].
Morré, DJ ;
Grieco, PA ;
Morré, DM .
LIFE SCIENCES, 1998, 63 (07) :595-604
[9]  
MORRE DJ, 1995, BBA-BIOMEMBRANES, V1236, P237
[10]   HELA PLASMA-MEMBRANES BIND THE ANTITUMOR SULFONYLUREA LY181984 WITH HIGH-AFFINITY [J].
MORRE, DJ ;
MORRE, DM ;
STEVENSON, J ;
MACKELLAR, W ;
MCCLURE, D .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1995, 1244 (01) :133-140